Fibrinolytic response to tumor necrosis factor in healthy subjects.

Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

1986 • 1,335 citations

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways

1990 • 796 citations

Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects

1990 • 681 citations

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways

1990 • 611 citations

Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

1988 • 561 citations

Peptide Regulatory Factors

1989 • 498 citations

Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal Subjects

1989 • 487 citations

A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma

1982 • 486 citations

Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.

1986 • 325 citations

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo

1988 • 300 citations

Regulation of endothelial cell coagulant properties

1989 • 255 citations

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo

1988 • 232 citations

Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA

1985 • 213 citations

Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine.

1987 • 209 citations

Measurement of Crosslinked Fibrin Degradation Products – An Immunoassay Using Monoclonal Antibodies

1983 • 204 citations

Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells

1990 • 182 citations

Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans

1989 • 165 citations

Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease

1990 • 155 citations

Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.

1991 • 115 citations

Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products

1990 • 109 citations

Quantitation of urokinase antigen in plasma and culture media by use of an elisa

1986 • 94 citations

Rapid microanalysis of coagulation parameters by automated chromogenic substrated methods - application in neonatal patients

1982 • 33 citations

Effect of tumor necrosis factor on the human fibrinolytic system.

1990 • 16 citations

Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans

1989 • 16 citations

Effect of Tumor Necrosis Factor on the Human Fibrinolytic System

1990 • 9 citations